LifeArc announces strategic partnership with PrecisionLife as part of its Motor Neuron Disease Translational Challenge

LifeArc and PrecisionLife will work together to select and validate multiple novel targets and their accompanying patient stratification biomarkers.

LifeArc & Cystic Fibrosis Trust announce new £15m research funding to fast track treatment of lung infections

Focussing on innovative approaches to improve quality of life for people with cystic fibrosis (CF)

Dr Jason Slingsby joins LifeArc as Chief Business Officer

Jason will be responsible for developing, leading, and implementing LifeArc’s business development and partnering strategies.

LifeArc launches £40m funding call to create Translational Rare Disease Centres

Centres to become focal points for rare disease research translation and engagement with the patient community across the UK.

LifeArc plans two major funding calls to boost translational research in rare disease & lung health in cystic fibrosis

The calls are part of our wider £100m programme to support scientific innovation for people living with cystic fibrosis.

LifeArc joins the Campaign for Science and Engineering

Network of over 115 members works to put research at the heart of the UK’s future.

LifeArc Ventures launches new brand with dedicated website, LinkedIn and Twitter

Enabling LifeArc Ventures to speak directly to fellow investors, life science companies and entrepreneurial scientists.

From donkeys to diversity – Anji Miller reports from AUTM 2023

Takeaways from AUTM's Annual Conference for the technology transfer sector

£3m fund to accelerate development of new CF therapies

Collaborative funding to drug discovery innovators to accelerate new treatments for people with cystic fibrosis.